Timothy Charles Boire
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2024First federal award
$4.7MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $4.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 21, 2026 | NIH | SBIR Phase II Pilot-Scale Synthesis for the Commercialization of a Novel, Bioabsorbable Perivascular Wrap to Improve Outcomes in Arteriovenous Fistula Creation and Other Vascular Surgeries | $1.0M | VenoStent, Inc. |
| May 19, 2026 | NIH | SBIR Phase II SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS | $1.2M | VenoStent, Inc. |
| May 15, 2025 | NIH | SBIR Phase II TABA for SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS | $50K | VenoStent, Inc. |
| Apr 24, 2025 | NIH | SBIR Phase II SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS | $1.2M | VenoStent, Inc. |
| May 1, 2024 | NIH | SBIR Phase II SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS | $1.2M | VenoStent, Inc. |
1 patents as inventor
- US VenoStent, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#315
Awards as PI#470
Patents#505
Companies
- VenoStent, Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.